Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
about
Contrast Medium-Induced Acute Kidney InjuryHemodynamic and tubular changes induced by contrast mediaClinical usefulness of urinary liver-type fatty-acid-binding protein as a perioperative marker of acute kidney injury in patients undergoing endovascular or open-abdominal aortic aneurysm repairEarly renal dysfunction after contrast media administration despite prophylactic hydrationContrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology.Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy.Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI RegistryPredictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies.Contrast induced nephropathy in urology.Periprocedural hemoglobin drop and contrast-induced nephropathy in percutaneous coronary intervention patients.Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center Experience.Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registryDevelopment of contrast-induced acute kidney injury after elective contrast media exposure in patients with type 2 diabetes mellitus: effect of albuminuria.Contrast-induced nephropathy in patients undergoing percutaneous coronary interventionEffect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced NephropathyComparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast induced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention.Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.Compound danshen dripping pill pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention.Cardiological Society of India practice guidelines for angiography in patients with renal dysfunction.Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: a retrospective cohort studyDetermination of safe contrast media dosage to estimated glomerular filtration rate ratios to avoid contrast-induced nephropathy after elective percutaneous coronary intervention.The importance of contrast volume/glomerular filtration rate ratio in contrast-induced nephropathy patients after transcatheter aortic valve implantationGuideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy.Contrast-induced nephropathy in interventional cardiologyEffects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-AnalysisIodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback.The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-AnalysisEfficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.Safe contrast volumes for preventing contrast-induced nephropathy in elderly patients with relatively normal renal function during percutaneous coronary intervention.Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography.Remote Ischemic Preconditioning for the Prevention of Contrast-Induced Acute Kidney Injury in Diabetics Receiving Elective Percutaneous Coronary InterventionThe Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry.Comparison of the efficacy of recombinant human brain natriuretic peptide with saline hydration in preventing contrast-induced nephropathy in patients undergoing coronary angiography with or without concomitant percutaneous coronary interventionRisk factors for contrast-induced nephropathy.The Impact of Remote Ischemic Pre-Conditioning on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Angioplasty: A Double-Blind Randomized Clinical Trial.Risk factors and therapy strategies for contrast-induced nephropathy.Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary interventionEffect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.
P2860
Q26801447-3F275F70-12F7-4228-9045-18D6AF4F8231Q26864323-09F27203-63DD-4FEC-8CE7-2C009EB5E37EQ28270013-1873BCB3-99E9-40C3-B470-7C40DF1CD7D1Q28680679-5E0D68A1-6739-4B55-833E-5FEAE449DA75Q30439077-841E9D65-8768-443E-A3F7-D85A13C4925CQ30487828-C0651A10-5E45-4F98-8CF4-322360563A49Q30878953-5C989D16-4867-41E6-88A7-7C467F00544AQ33383007-2318BB72-351D-476F-B7EF-23149FD73129Q33578171-7E2E45FC-3713-436C-8E6B-4FA5C01486DBQ33599720-FE65D2BC-B34A-407D-9E46-1AA6F43385FDQ33685017-31DE0387-9D7F-48C1-B67D-0F8A197A781AQ33729371-C94EE058-69F6-49BD-B388-04E20952A9DDQ34005294-26AA864E-FA6B-4863-B1BA-63503E15F256Q34142374-EDEF9748-4940-43D1-BE7D-BAF5C71536D0Q34155673-EC7C283F-DAFA-46D9-9466-D5F550EA0F39Q34269645-26E73A9D-481A-4602-AB8B-226F1F2F7D86Q34428322-8E9FFEE2-4B45-49DE-A4C1-5BE8E51AEC54Q34437133-EA9142B2-2D1F-48E2-8126-C677DE6BCD2DQ34438015-E8C7718A-D4B3-43C7-9FE9-45A737BD8037Q34467009-D06F5E68-6D7F-4C8B-ABAE-41E9B16E1D43Q34574872-B907AA7B-1388-40AF-9A14-F001B8D16CF2Q34816125-3BF96A33-61B5-469F-B381-3B86FB1D58D4Q35048384-70C086E1-A837-4517-9D08-38E0A94BAB22Q35081498-94225684-6DF1-4A77-B76B-2B5E09D21DF9Q35083828-A28352CD-07B7-4B2C-BB76-290AF400D9B4Q35193141-33132205-7920-4DCA-805A-D041B5CDE0FCQ35567418-0863798D-D5D9-4368-8DC3-6CEDEF6A489CQ35576454-F3A18B5A-59C8-4633-9C67-07AD43F73EF6Q35666177-17DDE1C6-122C-406C-A147-EA1ABAD7125DQ35930002-A7D20D7E-1AC5-434E-BEF2-717239D45A94Q36009044-DC1BA4F9-DCD9-4470-93C8-D17C008FE08FQ36085790-CA6AA5B8-04E5-4B2D-9462-9854AA40EB14Q36159523-8CDC2E10-A557-4AB6-B645-8F96D7035BE7Q36182190-35D96A12-7D3B-41F3-B191-D1699D354D39Q36183555-6345EC06-A25E-4A6A-9322-0EC7B0750DCFQ36481450-5FE2F9C8-18CD-43A5-A82B-6D9C9D06ABDFQ36497957-EADE3086-F008-45E3-9390-4CFFE0E57F3AQ36529372-8ABA12B2-3372-4721-83BE-3637B92449D5Q36626647-1C5B76AA-8767-4AB3-AD11-3B518708440BQ36680376-C5142796-A0DE-40A9-AA34-FCF973F96CEA
P2860
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Contrast-induced nephropathy a ...... ase and hemodynamic variables.
@en
Contrast-induced nephropathy a ...... ase and hemodynamic variables.
@nl
type
label
Contrast-induced nephropathy a ...... ase and hemodynamic variables.
@en
Contrast-induced nephropathy a ...... ase and hemodynamic variables.
@nl
prefLabel
Contrast-induced nephropathy a ...... ase and hemodynamic variables.
@en
Contrast-induced nephropathy a ...... ase and hemodynamic variables.
@nl
P2093
P1476
Contrast-induced nephropathy a ...... ase and hemodynamic variables.
@en
P2093
Alexandra J Lansky
Eugenia Nikolsky
Eve D Aymong
Gary S Mintz
Gregg W Stone
Ioannis Iakovou
Issam Moussa
Jeffrey W Moses
Martin B Leon
Nicholas N Kipshidze
P356
10.1016/J.AMJCARD.2004.08.056
P407
P577
2005-01-01T00:00:00Z